Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-088286
Filing Date
2025-09-08
Accepted
2025-09-08 16:31:14
Documents
2
Period of Report
2025-08-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2525415-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2525415-1_3seq1.xml 3 2512
2 EXHIBIT 24.1 tm2525415d1_ex24-1.htm EX-24.1 7494
  Complete submission text file 0001104659-25-088286.txt   11749
Mailing Address 23 HATA'AS STREET KFAR SABA Israel 44425
Business Address 23 HATA'AS STREET KFAR SABA Israel 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Issuer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 GRANTS ROW MOUNT STREET LOWER DUBLIN 2 Ireland D02HX96
Business Address
Lawlor Sally Bridget (Reporting) CIK: 0002084407 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37846 | Film No.: 251300446